course materials

1. N521-19B_21 Advanced Pharmacology Assignment 3 Module 7
N521-19B_21 Advanced Pharmacology Assignment 3 Module 7N521-19B_21 Advanced
Pharmacology Assignment 3 Module 7Permalink: https:// /n521-19b_21-adva…nment-3-
module-7/Assignment 3L. P., age 23, is a Hispanic woman who graduated from college last
year. She reports to the CNP in her local community mental health center. She began
working as an accountant 1 month after graduating. Approximately 2 months ago, she
moved into a two-bedroom apartment with another woman who works at the same
accounting firm. She states that her roommate recommended that she see a doctor to find
out if she has anemia or “some sort of fatigue syndrome.” She states that she has felt
“restless” and “on edge” for most of the past 9 months. N521-19B_21 Advanced
Pharmacology Assignment 3 Module 7. She becomes easily fatigued and irritable and has
difficulty concentrating and falling asleep. She states that sometimes her mind “just goes
blank,” and she is worried that her work performance is no longer excellent. She reports
that all her life she had good grades in school and was very successful in everything she
attempted. Although she has been “a worrier from the day I was born,” now she worries
more than she ever has and feels nervous “all the time.” L. P. reports that she has a good
relationship with her boyfriend but they do not get to see each other very often because he
is attending graduate school 100 miles away. She reports having a satisfying sexual
relationship with him. She denies having any problems with relationships with her parents,
roommate, or peers. She denies having any financial worries unless she is fired from her job
for poor work performance. She reports that she has always been healthy and has taken
good care of herself. The only medication she takes is birth control pills, which she has
taken for the past 4 years without any adverse effects.In a paper not to exceed six pages,
excluding title and reference pages, submit your answers to the following in an MS Word
document:What is L. P.’s likely diagnosis?List specific pharmacotherapeutic treatment goals
for L. P.Should the CNP order any labs for L. P. at this time? Why?What drug therapy would
the CNP likely prescribe? Why?What are the parameters for monitoring the success of the
therapy?Describe specific patient monitoring based on the prescribed therapy.List one or
two adverse reactions for the selected agent that would cause the CNP to change therapy.L.
P. returns to see the CNP after six weeks, complaining of still feeling anxious and had heard
of a medication called Klonopin that she would like to try; how should the CNP respond to
her request?What health promotion activities should be recommended for this
patient?What is L. P.’s long-term prognosis?Please use the Case Study Analysis rubric
provided to guide you in completing this assignment. It will be used to evaluate your

2. submitted work.Rubric – N521-19B_21 Advanced Pharmacology Assignment 3 Module
7Competency 40 36 33 0 Points EarnedCase Study questions
completely and thoroughly answered with accurate evidence-based ed rationales
Accurate and well defined discussion of all 10 questions for the case study using
current evidence-based resources. Accurate discussion of nine case study
questions presented with use of current evidence-based resources. N521-19B_21
Advanced Pharmacology Assignment 3 Module 7 Accurate discussion of 8 questions
using current evidence-based resources Missing response to questions or
inappropriate answers to questions. No use of evidence-based resources. /40 40
36 33 0 Evidence ofcritical thinkingtherapeutic decision-making in
drug selection and evaluation of patient carepathophysiology and current pharmacological
researchassessment of the effectiveness of drug therapyformulation of clinical care and
teaching plans for persons from diverse populations Well-defined evidence ofcritical
thinkingtherapeutic decision-making in drug selection and evaluation of patient
carepathophysiology and current pharmacological researchassessment of the effectiveness
of drug therapyformulation of clinical care and teaching plans for persons from diverse
populations N521-19B_21 Advanced Pharmacology Assignment 3 Module 7 Evidence of
critical thinking in prescriptive therapy, monitoring and adverse events. May have lacked a
teaching plan or pathophysiologic discussion. Evidence of critical thinking but incompletely
described therapeutic decision making and omitted teaching plan and pathophysiology.
Multiple bulleted points are absent or poorly defined in the assignment. There is no
demonstration of critical thinking. /40Competency 10 9 8 0
Points EarnedGrammar, spelling, and punctuation There are no errors in
grammar, spelling, and punctuation There are a few minor errors in grammar, spelling,
and punctuation that do not detract from the meaning (1-3 errors) There are major errors
in grammar, spelling, and punctuation .(4-5 errors) No content or more than 5 errors
/10Competency 10 9 8 0 APA Compliance The
paper meets APA formatting guidelines There are a few minor errors (1-3 errors)
There are significant errors in the format of the paper (4-5 errors) No content or
more than 5 errors /10Total Points
/100Competency 40 36 33 0 Points Earned Case Study questions completely and
thoroughly answered with accurate evidence-based ed rationales Accurate and well
defined discussion of all 10 questions for the case study using current evidence-based
resources. Accurate discussion of nine case study questions presented with use of current
evidence-based resources. Accurate discussion of 8 questions using current evidence-based
resources Missing response to questions or inappropriate answers to questions. No use of
evidence-based resources. N521-19B_21 Advanced Pharmacology Assignment 3 Module
7 /40 40 36 33 0 Evidence ofcritical thinkingtherapeutic decision-making in drug
selection and evaluation of patient carepathophysiology and current pharmacological
researchassessment of the effectiveness of drug therapyformulation of clinical care and
teaching plans for persons from diverse populationsWell-defined evidence ofcritical
thinkingtherapeutic decision-making in drug selection and evaluation of patient
carepathophysiology and current pharmacological researchassessment of the effectiveness

3. of drug therapyformulation of clinical care and teaching plans for persons from diverse
populationsEvidence of critical thinking in prescriptive therapy, monitoring and adverse
events. May have lacked a teaching plan or pathophysiologic discussion. Evidence of critical
thinking but incompletely described therapeutic decision making and omitted teaching plan
and pathophysiology. Multiple bulleted points are absent or poorly defined in the
assignment. There is no demonstration of critical thinking. /40 Competency 10 9 8 0 Points
Earned Grammar, spelling, and punctuation There are no errors in grammar, spelling, and
punctuation There are a few minor errors in grammar, spelling, and punctuation that do not
detract from the meaning (1-3 errors) There are major errors in grammar, spelling, and
punctuation .(4-5 errors) No content or more than 5 errors /10 Competency 10 9 8 0 APA
Compliance The paper meets APA formatting guidelines There are a few minor errors (1-3
errors) There are significant errors in the format of the paper (4-5 errors) No content or
more than 5 errors N521-19B_21 Advanced Pharmacology Assignment 3 Module
7 /10 Total Points /100Discussion 3M. L. is a 15-year-old Hispanic female who plays
soccer for her school team. She has noticed that when running, she sometimes has trouble
catching her breath. She also reports an increased runny nose and itchy eyes. She has a
frequent dry cough and is awakened with coughing spells at least four times a week. Her
mother and father have seasonal allergies and her mother has asthma. This morning she
woke up and heard “funny sounds” when she took a breath. Her coughing increased when
she took a deep breath. In her nose, the mucosa is pale and swollen bilaterally. Her lungs
have bilateral expiratory wheezing; respirations are 22 and PEF is 400. Her heart shows a
normal sinus rhythm, with no murmurs or gallops; pulse is 72; and there is no
cyanosis.Diagnosis: Mild Persistent AsthmaIn this discussion forum:Discuss specific goals of
pharmacotherapy for treating M. L.’s mild persistent asthma.Discuss the drug therapy a CNP
would likely prescribe and why.Discuss the parameters for monitoring the success of the
therapy.Discuss age appropriate health promotion recommendations you would consider
for M. L.Remember to respond to at least two of your peers. Please see the Course Syllabus
for Discussion Participation Requirements and Grading Criteria. N521-19B_21 Advanced
Pharmacology Assignment 3 Module 7Example Discussion 3 ApproachIn the United States,
asthma affects roughly 26 million people, with approximately 7 million of that figure
including children from the ages of 0-17 years old (Arcangelo, 2017). M.L. has been
diagnosed with mild persistent asthma and the goal of asthma therapy is to prevent
pulmonary dysfunction by maintaining a close to optimal pulmonary environment
(Arcangelo, 2017). Overall, pharmacotherapy should help M.L. with better tolerance of
physical activity, decrease, if not eliminate, the number of times she is awakened at night
due to dyspnea, and a decrease in rhinitis and itchy eyes from seasonal allergies.According
to the National Heart, Lung, and Blood Institute (2020), regardless of age, a short-term or
quick-acting medication is need. Medication management may include a short-term inhaled
beta 2 agonist that opens the airway by relaxing the muscles that are causing constriction
for exacerbations and an oral corticosteroid for persistent asthma to address the
inflammation created.Monitoring the success of therapy would include monitoring how
often she is experiencing symptoms during the day, how many times is she awakened at
night due to symptoms, how often is she using her inhaler, and how is she able to tolerate

4. physical activity (American Lung Association, 2020). According to Baylor College of
Medicine’s Rules of Two, asthma is uncontrolled if there are positives for one or more of the
following statements: use of inhaler is greater than twice a week, awakening at night due to
pulmonary symptoms is greater than twice a month, or if the inhaler is filled more than
twice in one year (American Lung Association, 2020).Health promotion and education is
important for those diagnosed with asthma, particularly school-aged children. Education
for M.L. would include identifying triggers that affect her asthma, take her medications as
prescribed, be able to identify symptoms of an exacerbation early, learn the proper use of
the inhaler, monitor her peak flow values, and have an asthma plan of action in place (
Hollier, 2018).ReferencesAmerican Lung Association. (2020, April 08). Assess and monitor
your asthma control. Retrieved from https://www.lung.org/lung-health-diseases/lung-
disease-lookup/asthma/living-with-asthma/managing-asthma/assess-and-monitor-
yourArcangelo, V.P., Peterson, A.M., Reinhold, J.A., & Wilbur, V.
(2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.).
Philadelphia, PA: Wolters Kluwer.Hollier, A. (2018). Clinical guidelines in primary
care. (3rd ed.). Lafayette, LA: Advanced Practice Education Associates.National Heart, Lung,
and Blood Institute. (2020, December 03). Asthma. Retrieved from
https://www.nhlbi.nih.gov/health-topics/asthma N521-19B_21 Advanced Pharmacology
Assignment 3 Module 7